Scott Requadt J.D., L.L.B., M.B.A., MBA
Net Worth
Last updated:
What is Scott Requadt J.D., L.L.B., M.B.A., MBA net worth?
The estimated net worth of Mr. Scott Requadt J.D., L.L.B., M.B.A., MBA is at least $1,634,280 as of 29 Jul 2022. He has received compensation worth at least $1,634,280 in Talaris Therapeutics, Inc..
What is the salary of Scott Requadt J.D., L.L.B., M.B.A., MBA?
Mr. Scott Requadt J.D., L.L.B., M.B.A., MBA salary is $544,760 per year as Pres, Chief Executive Officer, Sec. & Director in Talaris Therapeutics, Inc..
How old is Scott Requadt J.D., L.L.B., M.B.A., MBA?
Mr. Scott Requadt J.D., L.L.B., M.B.A., MBA is 57 years old, born in 1968.
What stocks does Scott Requadt J.D., L.L.B., M.B.A., MBA currently own?
As insider, Mr. Scott Requadt J.D., L.L.B., M.B.A., MBA owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Talaris Therapeutics, Inc. (TALS) | Pres, Chief Executive Officer, Sec. & Director | 508,680 | $0 | $0 |
What does Talaris Therapeutics, Inc. do?
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immune, or metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.
Scott Requadt J.D., L.L.B., M.B.A., MBA insider trading
Talaris Therapeutics key executives
Talaris Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Suzanne T. Ildstad M.D. (72) Founder, Chief Scientific Officer & Director
- Mr. Scott Requadt J.D., L.L.B., M.B.A., MBA (57) Pres, Chief Executive Officer, Sec. & Director
- Ms. Nancy Krieger M.D. (58) Chief Medical Officer